Follicular Lymphoma IV/SC Rituximab Therapy (FLIRT)
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 202
Summary
- Conditions
- Follicular Lymphoma
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02303119
- Collaborators
- Roche Pharma AG
- Investigators
- Study Chair: Guillaume Cartron, MD PhD Lymphoma Study Association
Get Well Soon